Futura Medical is an innovative R&D company with a pipeline of products in late stage development. We are experts in topical formulations and transdermal delivery and have developed an advanced proprietary, transdermal drug delivery technology, DermaSys®.
Our strategy is to develop our innovative product portfolio to late stage and then partner at the optimum time to generate most value.
We are based in Guildford, UK and are listed on the AIM market of the London Stock Exchange.